BR112016016737A2 - Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma - Google Patents

Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma

Info

Publication number
BR112016016737A2
BR112016016737A2 BR112016016737A BR112016016737A BR112016016737A2 BR 112016016737 A2 BR112016016737 A2 BR 112016016737A2 BR 112016016737 A BR112016016737 A BR 112016016737A BR 112016016737 A BR112016016737 A BR 112016016737A BR 112016016737 A2 BR112016016737 A2 BR 112016016737A2
Authority
BR
Brazil
Prior art keywords
anaplasma
methods
peptides
devices
detection
Prior art date
Application number
BR112016016737A
Other languages
English (en)
Other versions
BR112016016737B1 (pt
Inventor
K Mehra Rajesh
P Aron Kenneth
M Bleile Dennis
P Rogers Andrew
p forsyth Timothy
D Walker Jeremy
R Cuesico Cristina
Original Assignee
Zoetis Services Llc
Abay Sa
Abaxis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc, Abay Sa, Abaxis Llc filed Critical Zoetis Services Llc
Publication of BR112016016737A2 publication Critical patent/BR112016016737A2/pt
Publication of BR112016016737B1 publication Critical patent/BR112016016737B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/29—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Richettsiales (o)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PEPTÍDEOS, DISPOSITIVOS E MÉTODOS PARA DETECÇÃO DE ANTICORPOS CONTRA ANAPLASMA. A invenção fornece populações de peptídeos isolados, úteis para a detecção de anticorpos que se ligam a antígenos de Anaplasma. As populações de peptídeos compreendem os peptídeos derivados de fragmentos imunogênicos das proteínas de Proteína de Membrana Externa de Anaplasma. A invenção também proporciona dispositivos, métodos e kits compreendendo as populações de peptídeos isolados, úteis para a detecção de anticorpos que se ligam a antígenos de Anaplasma e o diagnóstico da anaplasmose. Os métodos de identificação da espécie particular de Anaplasma infectando um sujeito utilizando as populações de peptídeos da invenção são também divulgados.
BR112016016737-6A 2014-01-21 2015-01-21 Composição, método para detectar numa amostra um anticorpo para um epítopo de um antígeno de anaplasma, método para o diagnóstico da anaplasmose num sujeito, kit, e método para identificar as espécies de anaplasma infectando um sujeito BR112016016737B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461929655P 2014-01-21 2014-01-21
US61/929,655 2014-01-21
US14/511,916 US9194870B2 (en) 2014-01-21 2014-10-10 Peptides, devices, and methods for the detection of Anaplasma antibodies
US14/511,916 2014-10-10
PCT/US2015/012187 WO2015112558A2 (en) 2014-01-21 2015-01-21 Peptides, devices, and methods for the detection of anaplasma antibodies

Publications (2)

Publication Number Publication Date
BR112016016737A2 true BR112016016737A2 (pt) 2017-10-03
BR112016016737B1 BR112016016737B1 (pt) 2024-01-02

Family

ID=53544557

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016016737-6A BR112016016737B1 (pt) 2014-01-21 2015-01-21 Composição, método para detectar numa amostra um anticorpo para um epítopo de um antígeno de anaplasma, método para o diagnóstico da anaplasmose num sujeito, kit, e método para identificar as espécies de anaplasma infectando um sujeito

Country Status (12)

Country Link
US (4) US9194870B2 (pt)
EP (2) EP3096784B1 (pt)
JP (1) JP6738274B2 (pt)
KR (1) KR102559678B1 (pt)
CN (1) CN105916518A (pt)
AU (1) AU2015209461B2 (pt)
BR (1) BR112016016737B1 (pt)
CA (1) CA2933376C (pt)
ES (1) ES2767183T3 (pt)
HU (1) HUE047156T2 (pt)
PT (1) PT3096784T (pt)
WO (1) WO2015112558A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133525B2 (en) 2012-01-26 2015-09-15 Luc Montagnier Detection of DNA sequences as risk factors for HIV infection
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies
US9956123B2 (en) * 2016-03-02 2018-05-01 Alphal Engineering Technology Group, Inc. Anti-microbial balanced weave wearable undergarment and process therefore
EP3428646A4 (en) * 2016-03-09 2019-10-23 Dai Nippon Toryo Co., Ltd. COMPOSITION FOR IDENTIFYING A SUBSTANCE TO BE INVESTIGATED WITH GOLD PANELS AND USE THEREOF
CN106324253A (zh) * 2016-08-12 2017-01-11 江苏泽成生物技术有限公司 一种***抗体测定试剂盒及其检测方法
BR102017002668A2 (pt) 2017-02-09 2018-10-30 Biotick Pesquisa E Desenvolvimento Tecnologico Ltda peptídeo híbrido, conjunto de peptídeos híbridos, composição, usos do peptídeo híbrido, método de induzir resposta imune e kits
CN107137060B (zh) * 2017-04-14 2019-11-05 同济大学 一种易代谢的金纳米球/鸡卵清蛋白复合纳米光声探针及其制备
JP7041491B2 (ja) * 2017-10-31 2022-03-24 田中貴金属工業株式会社 バイオアッセイのための検出剤及びそれを用いたシグナルの増幅方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US5965702A (en) 1991-10-21 1999-10-12 Abbott Laboratories Borrelia burgdorferi antigens and uses thereof
US5618533A (en) 1992-02-11 1997-04-08 Yale University Flagellin-based polypeptides for the diagnosis of lyme disease
US5932220A (en) 1995-05-08 1999-08-03 Board Of Regents University Of Texas System Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov.
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6207169B1 (en) 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6403093B1 (en) 1997-03-21 2002-06-11 Mayo Foundation For Medical Education And Research Methods to detect granulocytic ehrlichiosis
US6231869B1 (en) 1997-03-21 2001-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6204252B1 (en) 1997-04-25 2001-03-20 Aquila Biopharmaceuticals, Inc. Characterization of granulocytic ehrlichia and methods of use
CA2258266A1 (en) 1997-04-25 1998-11-05 Aquila Biopharmaceuticals, Inc. Nucleic acids, proteins, and methods of use of granulocytic ehrlichia
WO1999013720A1 (en) 1997-09-19 1999-03-25 The Ohio State Research Foundation Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis
US6436399B1 (en) 1998-04-09 2002-08-20 The Ohio State University Research Foundation Nucleic acid encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
US6355777B1 (en) 2000-04-28 2002-03-12 Research Development Foundation P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
US20030194756A1 (en) 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7407770B2 (en) 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7204992B2 (en) 2002-11-04 2007-04-17 Clayton Foundation For Research P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
US7304139B2 (en) 2003-10-28 2007-12-04 University Of Florida Research Foundation, Inc. Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
US20060046310A1 (en) 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
US7390626B2 (en) 2005-02-25 2008-06-24 Immunosciences Lab., Inc. Methods and kit for diagnosing tick borne illnesses
EP1891095A2 (en) 2005-06-16 2008-02-27 Research Development Foundation Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis
PL1895015T3 (pl) 2005-06-17 2013-02-28 Inst De Salud Carlos Iii Sposób i zestaw do wykrywania gatunków bakteryjnych za pomocą analizy DNA
WO2007133623A2 (en) 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
US7776618B2 (en) 2007-03-01 2010-08-17 Church & Dwight Co., Inc. Diagnostic detection device
US7507789B2 (en) 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
US8784828B2 (en) 2007-05-04 2014-07-22 The Ohio State University Research Foundation Ehrlichia ewingii proteins, nucleic acids, and methods of their use
ES2327593B1 (es) 2007-06-29 2010-08-05 Instituto De Salud Carlos Iii Metodo de identificacion de especies bacterianas de los generos anaplasma/ehrlichia y bartonella.
US8158370B2 (en) 2007-11-27 2012-04-17 Idexx Laboratories, Inc. Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma
TWI586365B (zh) 2008-10-08 2017-06-11 英代斯實驗公司 用於偵測對嗜吞噬細胞邊蟲（ａｐｈ）及片狀邊蟲（ａｐｌ）具專一性之抗體之組合物及方法
US8257938B2 (en) 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
WO2011063003A2 (en) 2009-11-17 2011-05-26 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
JP6161291B2 (ja) * 2009-11-20 2017-07-12 アバクシス， インコーポレイテッド エールリッヒア抗体の検出のためのペプチド、装置、および方法
US8455211B2 (en) 2010-07-15 2013-06-04 Medical Diagnostic Laboratories, Llc Anaplasma translocated substrate-1 (ATS-1) and sero-detection of Anaplasma phagocytophilum
US20140162256A1 (en) 2011-03-31 2014-06-12 Yasuko Rikihisa Compositions and methods for the detection of anaplasma platys
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
CN105051541B (zh) 2012-10-11 2017-07-04 爱贝斯股份有限公司 用于检测埃里希体属抗体的肽、装置和方法
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies

Also Published As

Publication number Publication date
WO2015112558A3 (en) 2015-09-03
US9194870B2 (en) 2015-11-24
EP3636277A1 (en) 2020-04-15
JP6738274B2 (ja) 2020-08-12
JP2017505436A (ja) 2017-02-16
AU2015209461B2 (en) 2019-08-22
US20190277857A1 (en) 2019-09-12
BR112016016737B1 (pt) 2024-01-02
ES2767183T3 (es) 2020-06-16
WO2015112558A2 (en) 2015-07-30
KR102559678B1 (ko) 2023-07-27
US20160109457A1 (en) 2016-04-21
PT3096784T (pt) 2020-01-21
CN105916518A (zh) 2016-08-31
US9702883B2 (en) 2017-07-11
US20170363639A1 (en) 2017-12-21
AU2015209461A1 (en) 2016-06-30
US10330687B2 (en) 2019-06-25
CA2933376A1 (en) 2015-07-30
EP3096784B1 (en) 2019-11-20
EP3096784A2 (en) 2016-11-30
EP3096784A4 (en) 2017-12-06
HUE047156T2 (hu) 2020-04-28
CA2933376C (en) 2023-09-26
US11131675B2 (en) 2021-09-28
KR20160108521A (ko) 2016-09-19
US20150204868A1 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
BR112016016737A2 (pt) Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma
CL2020000192A1 (es) Anticuerpos anti-cd8 y usos de estos.
BR112018070260A2 (pt) receptores quiméricos e métodos de uso dos mesmos
CO2018011668A2 (es) Neoantígenos y métodos de su uso
BR112017017293A2 (pt) método para predizer modificações de aminoácidos, para selecionar e/ou classificar modificações de aminoácidos e para fornecer uma vacina e vacina
BR112017008165A2 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
EA201791148A1 (ru) Способ определения абсолютных количеств hla-рестриктированных раковых пептидов, образовавшихся в результате естественного процессинга
EA201692394A1 (ru) Антитела и антигенсвязывающие фрагменты, которые специфично связываются с белком тау, ассоциированным с микротрубочками
BR112018011073A2 (pt) anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes e métodos de utilização
UY36304A (es) Proteínas de fusión, bacterias recombinantes y métodos de uso de las bacterias recombinantes
BR112019018307A2 (pt) Plataforma para identificação de peptídeos imunogênicos baseada em população
BR112017006736A2 (pt) anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes, e métodos de utilização
BR112016027805A2 (pt) receptores de células t do anti-papilomavírus humano 16 e7
BR112017006598A2 (pt) anticorpo de repetições antidipeptídeo derivado de ser humano (dprs)
BR112014026755B8 (pt) anticorpos contra claudin 18.2 úteis no diagnóstico de câncer
EA201892325A1 (ru) Композиции и способы детектирования белков клетки-хозяина
BR112019012796A2 (pt) proteínas de ligação ao antígeno antineuropilina e métodos de uso das mesmas
BR112017009790A2 (pt) anticorpos direcionados ao anti-ang2 e métodos de uso
BR112015008036A2 (pt) população de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica e kit
MX2017008096A (es) Pestivirus.
MX2016013584A (es) Parvovirus porcino.
BR112018008840A8 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
BR112017002622A2 (pt) métodos e sistemas para quantificação seletiva e detecção de alergênicos
BR112016015537A2 (pt) métodos e kits para detectar a presença de sequência polinucleotídea da e. histolytica em amostra
BR112018073660A2 (pt) anticorpos anti-fator ix pádua

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25D Requested change of name of applicant approved

Owner name: ABAXIS LLC (US)

B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/01/2015, OBSERVADAS AS CONDICOES LEGAIS